Switch iconSwitch
Homepage iconHomepage facebook iconfacebook IG iconIG Hospital iconOther Hospital CMUH APP iconCMUH App
About CMUH

News and Award

:::
Home/
About CMUH/
News and Award/
Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers

About CMUH

2025/2/17

Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers

Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers

Authors: Hsien-Yuan Lane), Chieh-Hsin Lin

Journal: Int J Neuropsychopharmacol

Publication Date: 2023

Image Source: Int J Neuropsychopharmacol

Link: https://pubmed.ncbi.nlm.nih.gov/35986919/

回上頁

Related Articles

Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research img
Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research
Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial img
Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial
Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline img
Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline
Stay connected with CMUH
facebook Facebook
IG
youtube YouTube
How to get to CMUH the map of hospital
Download
▲